Category: Forbes

New Insights Into The Anti-Aging Properties Of Klotho

The Klotho gene has gained increasing attention for its anti-aging properties. A new study finds that the benefits of this circulating hormone extend beyond the brain.

For Certain Drugs Medicare Selects For Price Negotiation It May Be A Challenge To Get Deeper Discounts Than Current Rebates

For certain drugs Medicare selects for price negotiation it may be difficult to achieve deeper discounts than the rebates these pharmaceuticals currently face.

FDA: Frito-Lay Recalls 2 Sizes Of Doritos Nacho Cheese Flavored Tortilla Chips

Frito-Lay has issued a voluntary recall of certain lots of its 14.5-ounce and 1-ounce Doritos Nacho Cheese Flavored Tortilla Chips.

What To Know About Zuranolone—The First FDA-Approved Oral Pill For Postpartum Depression

About one in seven women experience postpartum depression after giving birth.

Study: 85% Of Healthcare Workers Nose-Pick, More Than Triples Covid-19 Risk

Those who admitted picking their noses were 3.8 times as likely to catch the severe acute coronavirus 2 (SARS-CoV-2) as those who claimed that they didn’t.

FDA Approves Zurzuvae, First Pill For Postpartum Depression, What You Need To Know

Zurzuvae is the first ever oral medication for postpartum depression, a major depressive episode that affects an estimated one in seven mothers.

Innovations In Skeletal Regeneration: Bridging The Gap In Bone Health

New artificial implant scaffolding methods may be the next great leap in bone healing medicine.

A Closer Look At Protein-Based Therapies For Dry Macular Degeneration

In Clinical Ophthalmology, a review examined the investigational therapeutics for treating dry age-related macular degeneration, including protein-based therapies.

Otter Attacks 3 Women On Jefferson River In Montana

News of this river otter attack comes several weeks after news emerged of a sea otter in Santa Cruz stealing surfboards.

Walgreens Sells AmerisourceBergen Shares To Raise $1.85 Billion To Accelerate Healthcare Strategy

Walgreens Boots Alliance has sold shares of AmerisourceBergen for initial proceeds of $2.85 billion, which will be used to accelerate the drugstore giant’s healthcare strategy.